| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-OGFOD1 (1-140) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
| Purification: |
Affinity purification |
| Dilution Range: |
WB 1:500-1:2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
OGFOD1 |
| Gene ID: |
55239 |
| Uniprot ID: |
OGFD1_HUMAN |
| Immunogen Region: |
1-140 |
| Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-140 of human OGFOD1 (NP_060703.3). |
| Immunogen Sequence: |
MNGKRPAEPGPARVGKKGKK EVMAEFSDAVTEETLKKQVA EAWSRRTPFSHEVIVMDMDP FLHCVIPNFIQSQDFLEGLQ KELMNLDFHEKYNDLYKFQQ SDDLKKRREPHISTLRKILF EDFRSWLSDISKIDLESTID |
| Function | Prolyl 3-hydroxylase that catalyzes 3-hydroxylation of 'Pro-62' of small ribosomal subunit uS12 (RPS23), thereby regulating protein translation termination efficiency. Involved in stress granule formation. |
| Protein Name | Prolyl 3-Hydroxylase Ogfod12-Oxoglutarate And Iron-Dependent Oxygenase Domain-Containing Protein 1Termination And Polyadenylation 1 HomologUs12 Prolyl 3-Hydroxylase |
| Cellular Localisation | Isoform 1: CytoplasmNucleusMainly NuclearA Portion Relocalizes To Cytoplasmic Stress Granules Upon StressIsoform 2: Cytoplasm |
| Alternative Antibody Names | Anti-Prolyl 3-Hydroxylase Ogfod1 antibodyAnti-2-Oxoglutarate And Iron-Dependent Oxygenase Domain-Containing Protein 1 antibodyAnti-Termination And Polyadenylation 1 Homolog antibodyAnti-Us12 Prolyl 3-Hydroxylase antibodyAnti-OGFOD1 antibodyAnti-KIAA1612 antibodyAnti-TPA1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
